In vitro activity of liposomal N4octadecyl-1-β-D-arabinofuranosylcytosine (NOAC), a new lipophilic derivative of 1-β-D-arabinofuranosylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells

Investigational New Drugs

Volumn 19, Issue 3, 2001, Pages 203-210

  Schwendener, R A ^a   Friedl, K ^b   Depenbrock, H ^b   Schott, H ^c   Hanauske, A R ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Clonogenic growth; Human tumors; In vitro activity; Lipophilic ara C derivative; Liposomes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; CYTARABINE DERIVATIVE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; LIPOSOME; MITOMYCIN C; N4 OCTADECYL 1 BETA DEXTRO ARABINOFURANOSYLCYTOSINE; NEW DRUG; NSC 685096; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLONOGENESIS; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LIPOPHILICITY; LYOPHILISATE; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CLONE CELLS; CYTARABINE; DOXORUBICIN; HEMATOPOIETIC STEM CELLS; HUMANS; LIPOSOMES; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0034857159     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010679411001     Document Type: Article

References (20)

1. Synthese von 4-alkylcytosin-nukleosiden und deren cytotstatische wirkung im L1210 leukämiemodell der maus
2. 4-hexadecy-1-β-D-arabinofuranosylcytosine
3. 4-octa-decyl-ara-C, NOAC
4. 4-alkyl derivatives of 1-β-D-arabinofuranosylcytosine (ara-C)
5. 4-hexadecyl-1-β-D-arabinofuranosylcytosine, a lipophilic derivative of 1-β-D-arabinofuranosylcytosine
6. 4-hexadecyl-1-β-D-arabinofuranosylcytosine (NHAC) in the human leukemic cell lines K-562 and U-937
7. 4-hexadecyl-1-β-D-arabinofuranosylcytosine, a new lipophilic derivative of 1-β-D-arabinofuranosylcytosine
8. 4-octadecyl-1-β-D-arabinofuranosylcytosine, a new anticancer drug
9. 4-octadecyl-1-β-D-arabinofuranosylcytosine (NOAC) in Daudi lymphoma cells
10. 4-octadecyl-1-β-D-arabinofuranosylcytosine in mice
11. Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumors in vitro
12. In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumor cells and haematopoietic precursor cells
13. Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units
14. Preclinical activity of trans-indazolium [tetra-chlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumor colony-forming units and haematopoietic progenitor cells
15. Recent improvements in the human tumor cloning assay for sensitivity testing of antineoplastic agents
16. Biphasic effect of vanadium salts on in vitro tumor colony growth
17. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
18. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
19. 4-octadecyl-1-β -D-ara-C
20. 4-octadecyl-1-β-D-arabinofuranosylcytosine in liposomal preparations